Ladenburg Thalmann is bookrunner, Cantor Fitzgerald is lead manager
By Devika Patel
Knoxville, Tenn., Nov. 19 – Axsome Therapeutics, Inc. said it priced its $51 million initial public offering of stock with a $7.65 million greenshoe.
The company will sell 5,666,667 common shares at $9.00 apiece.
Ladenburg Thalmann & Co. Inc. is the bookrunning manager.
Settlement is expected Nov. 24.
The biopharmaceutical company is based in New York. The company expects its shares will trade on the Nasdaq under the symbol “AXSM.”
| Issuer: | Axsome Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $51 million
|
| Greenshoe: | $7.65 million, or 850,000 shares
|
| Shares: | 5,666,667
|
| Price: | $9.00
|
| Warrants: | No
|
| Bookrunner: | Ladenburg Thalmann & Co. Inc.
|
| Lead manager: | Cantor Fitzgerald & Co.
|
| Co-manager: | Brean Capital, LLC
|
| Pricing date: | Nov. 19
|
| Settlement date: | Nov. 24
|
| Expected listing: | Nasdaq: AXSM
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
